V. López-Gómez

1.1k total citations
23 papers, 830 citations indexed

About

V. López-Gómez is a scholar working on Experimental and Cognitive Psychology, Clinical Psychology and Psychiatry and Mental health. According to data from OpenAlex, V. López-Gómez has authored 23 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Experimental and Cognitive Psychology, 9 papers in Clinical Psychology and 6 papers in Psychiatry and Mental health. Recurrent topics in V. López-Gómez's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (13 papers), Child and Adolescent Psychosocial and Emotional Development (8 papers) and Pain Management and Opioid Use (4 papers). V. López-Gómez is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (13 papers), Child and Adolescent Psychosocial and Emotional Development (8 papers) and Pain Management and Opioid Use (4 papers). V. López-Gómez collaborates with scholars based in Spain, Netherlands and United Kingdom. V. López-Gómez's co-authors include Miguel A. Ruíz, Javier Rejas, Javier Garcı́a-Campayo, María Pérez‐Páramo, Enric Zamorano, Antonio Pardo, María Pérez, Xavier Masramón, David Abejón and César Margarit and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Medical Virology and Health and Quality of Life Outcomes.

In The Last Decade

V. López-Gómez

19 papers receiving 801 citations

Peers

V. López-Gómez
V. López-Gómez
Citations per year, relative to V. López-Gómez V. López-Gómez (= 1×) peers Wenzheng Wang

Countries citing papers authored by V. López-Gómez

Since Specialization
Citations

This map shows the geographic impact of V. López-Gómez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. López-Gómez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. López-Gómez more than expected).

Fields of papers citing papers by V. López-Gómez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. López-Gómez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. López-Gómez. The network helps show where V. López-Gómez may publish in the future.

Co-authorship network of co-authors of V. López-Gómez

This figure shows the co-authorship network connecting the top 25 collaborators of V. López-Gómez. A scholar is included among the top collaborators of V. López-Gómez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. López-Gómez. V. López-Gómez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perea, José Ramón Azanza, Juan González del Castillo, José Molero, et al.. (2025). Cost‐Effectiveness of Nirmatrelvir/Ritonavir in COVID‐19 Patients at High‐Risk for Progression in Spain. Journal of Medical Virology. 97(3). e70288–e70288.
3.
Olivares, J.M., et al.. (2015). Pregabalin for the treatment of patients with generalized anxiety disorder with inadequate treatment response to antidepressants and severe depressive symptoms. International Clinical Psychopharmacology. 30(5). 265–271. 11 indexed citations
4.
Álvarez, Enric, J.M. Olivares, José Luís Carrasco, V. López-Gómez, & Javier Rejas. (2015). Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors. Annals of General Psychiatry. 14(1). 2–2. 6 indexed citations
6.
Sepúlveda-Sánchez, Juan Manuel, et al.. (2013). The Prevalence and Nature of Cancer-Related Neuropathic Pain in Out-Patient Services in Spain. 6(1). 199–207. 1 indexed citations
7.
Olivares, J.M., José Luís Carrasco, Enric Álvarez, et al.. (2013). The effect of broadening the definition of generalized anxiety disorder on healthcare resource utilization and related costs in outpatient psychiatric clinics. Open Journal of Psychiatry. 3(1). 158–167.
8.
Garcı́a-Campayo, Javier, Enric Zamorano, Miguel A. Ruíz, et al.. (2012). The assessment of generalized anxiety disorder: psychometric validation of the Spanish version of the self-administered GAD-2 scale in daily medical practice. Health and Quality of Life Outcomes. 10(1). 114–114. 69 indexed citations
9.
Garcı́a-Campayo, Javier, Enric Zamorano, Miguel A. Ruíz, et al.. (2012). P-149 - Psychometric validation of the spanish version of the GAD-2 scale for screening generalized anxiety disorder. European Psychiatry. 27. 1–1. 3 indexed citations
10.
Álvarez, Enric, et al.. (2012). Broadening of Generalized Anxiety Disorders Definition Does not Affect the Response to Psychiatric Care: Findings from the Observational ADAN Study. Clinical Practice and Epidemiology in Mental Health. 8(1). 158–168. 10 indexed citations
12.
Fernández, M.C., et al.. (2011). Post hoc analysis of pregabalin vs. non-pregabalin treatment in patients with cancer-related neuropathic pain: better pain relief, sleep and physical health. Clinical & Translational Oncology. 13(9). 656–663. 18 indexed citations
13.
Bobes, Julio, et al.. (2011). Pregabalin for the discontinuation of long-term benzodiazepines use: An assessment of its effectiveness in daily clinical practice. European Psychiatry. 27(4). 301–307. 36 indexed citations
14.
Andrés, José De, J. Pérez‐Cajaraville, César Margarit, et al.. (2011). Cultural Adaptation and Validation of the painDETECT Scale Into Spanish. Clinical Journal of Pain. 28(3). 243–253. 81 indexed citations
15.
Rubio, Gabriel, et al.. (2011). Effects of Pregabalin on Subjective Sleep Disturbance Symptoms during Withdrawal from Long-Term Benzodiazepine Use. European Addiction Research. 17(5). 262–270. 13 indexed citations
16.
Pablos‐Velasco, Pedro de, et al.. (2010). Prevalence of distal diabetic polyneuropathy using quantitative sensory methods in a population with diabetes of more than 10 years’ disease duration. Endocrinología y Nutrición. 57(9). 414–420. 32 indexed citations
17.
Garcı́a-Campayo, Javier, Enric Zamorano, Miguel A. Ruíz, et al.. (2010). Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool. Health and Quality of Life Outcomes. 8(1). 8–8. 473 indexed citations
18.
Flórez-García, Mariano Tomás, et al.. (2010). A Cost-Consequence Analysis of Pregabalin versus Usual Care in the Symptomatic Treatment of Refractory Low Back Pain. Clinical Drug Investigation. 30(8). 517–531. 13 indexed citations
19.
López-Gómez, V., et al.. (2010). Prevalence of Neuropathic Pain in Radiotherapy Oncology Units. International Journal of Radiation Oncology*Biology*Physics. 81(2). 511–520. 29 indexed citations
20.
Garcı́a-Campayo, Javier, Enric Zamorano, Miguel A. Ruíz, et al.. (2009). Cultural Adaptation into Spanish of the Generalized Anxiety Disorder Scale - 7 (GAD-7) Scale. European Psychiatry. 24(S1). 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026